Atovaquone Structural Formula (039ad3a4 D2db 40c8 Be97 F44218149744 01)
Atovaquone And Proguanil Hydrochloride Tablet, Film Coated
Product Images NDC 51407-869
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hydrochloride (NDC 51407-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Proguanil Hydrochloride Structural Formula (039ad3a4 D2db 40c8 Be97 F44218149744 02)
51407-869-01lb (Atovaquone Pronguanil HCI)
This text provides information about Atovaquone and Proguanil Hydrochloride tablets. Each tablet contains 250 mg Atovaquone and 100 mg Proguanil hydrochloride. The dosage details are provided in the accompanying Prescribing Information. The tablets should be stored in a tight, light-resistant container at 20° - 25°C (68° - 77°F). It is essential to keep the container closed and away from children. It is also mentioned that the tablets should not be used if the safety seal under the cap is broken or missing. The tablets are marketed by GSMS, Incorporated in Camarillo, CA, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
